17194517|t|Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
17194517|a|Butyrylcholinesterase (EC 3.1.1.8 BChE) is present in all human and mouse tissues, and is more abundant than acetylcholinesterase (EC 3.1.1.7 AChE) in all tissues except brain. People who have no BChE activity due to a genetic variation are healthy. This has led to the hypothesis that BChE has no physiological function. We tested this hypothesis by challenging BChE and AChE knockout mice, as well as wild-type mice, with the AChE specific inhibitors, (--)-huperzine A and donepezil, and with serine hydrolase inhibitors, echothiophate and chlorpyrifos oxon. (--)-Huperzine A and donepezil caused mortality and significant toxicity in the BChE-/- animals. The BChE heterozygote (BCHE+/-) mice with approximately one-half the BChE activity of the BChE wild type (BChE+/+) exhibited intermediate toxic symptoms, and survived a longer period. The BChE+/+ animals displayed comparatively minor toxic symptoms and recovered by 24h post-dosing. Plasma AChE activity was inhibited to the same extent in BChE-/-, +/-, and +/+ mice, whereas BChE activity was not inhibited. This indicated that the protective effect of BChE was not due to scavenging (--)-huperzine A. AChE-/- mice were unaffected by (--)-huperzine A and donepezil, demonstrating the specificity of these inhibitors for AChE. AChE-/- mice treated with chlorpyrifos oxon lost all BChE activity, had severe cholinergic symptoms and died of convulsions. This showed that BChE activity was essential for survival of AChE-/- mice. In conclusion, we propose that the protective effect of BChE is explained by hydrolysis of excess acetylcholine in physiologically relevant regions such as diaphragm, cardiac muscle, and brain. Thus, BChE has a function in neurotransmission. People with BChE deficiency are expected to be intolerant of standard doses of the anti-Alzheimer's drugs, (--)-huperzine A and donepezil.
17194517	15	36	butyrylcholinesterase	Gene	12038
17194517	46	50	mice	Species	10090
17194517	59	70	huperzine A	Chemical	MESH:C050426
17194517	75	84	donepezil	Chemical	MESH:D000077265
17194517	94	100	humans	Species	9606
17194517	106	138	butyrylcholinesterase deficiency	Disease	MESH:C537417
17194517	162	181	Alzheimer's disease	Disease	MESH:D000544
17194517	202	223	butyrylcholinesterase	Gene	590
17194517	255	276	Butyrylcholinesterase	Gene	590
17194517	289	293	BChE	Gene	590
17194517	313	318	human	Species	9606
17194517	323	328	mouse	Species	10090
17194517	364	384	acetylcholinesterase	Gene	43
17194517	397	401	AChE	Gene	43
17194517	451	455	BChE	Gene	590
17194517	541	545	BChE	Gene	12038
17194517	618	622	BChE	Gene	12038
17194517	627	631	AChE	Gene	11423
17194517	641	645	mice	Species	10090
17194517	668	672	mice	Species	10090
17194517	683	687	AChE	Gene	11423
17194517	714	725	huperzine A	Chemical	MESH:C050426
17194517	730	739	donepezil	Chemical	MESH:D000077265
17194517	779	792	echothiophate	Chemical	MESH:C061212
17194517	797	814	chlorpyrifos oxon	Chemical	MESH:C009618
17194517	821	832	Huperzine A	Chemical	MESH:C050426
17194517	837	846	donepezil	Chemical	MESH:D000077265
17194517	880	888	toxicity	Disease	MESH:D064420
17194517	896	900	BChE	Gene	12038
17194517	917	921	BChE	Gene	12038
17194517	936	940	BCHE	Gene	12038
17194517	945	949	mice	Species	10090
17194517	982	986	BChE	Gene	12038
17194517	1003	1007	BChE	Gene	12038
17194517	1019	1023	BChE	Gene	12038
17194517	1051	1056	toxic	Disease	MESH:D064420
17194517	1101	1105	BChE	Gene	12038
17194517	1147	1152	toxic	Disease	MESH:D064420
17194517	1203	1207	AChE	Gene	11423
17194517	1253	1257	BChE	Gene	12038
17194517	1275	1279	mice	Species	10090
17194517	1289	1293	BChE	Gene	12038
17194517	1367	1371	BChE	Gene	12038
17194517	1403	1415	huperzine A.	Chemical	MESH:C050426
17194517	1416	1420	AChE	Gene	11423
17194517	1424	1428	mice	Species	10090
17194517	1453	1464	huperzine A	Chemical	MESH:C050426
17194517	1469	1478	donepezil	Chemical	MESH:D000077265
17194517	1534	1539	AChE.	Gene	11423
17194517	1540	1544	AChE	Gene	11423
17194517	1548	1552	mice	Species	10090
17194517	1566	1583	chlorpyrifos oxon	Chemical	MESH:C009618
17194517	1593	1597	BChE	Gene	12038
17194517	1619	1630	cholinergic	Disease	MESH:C535672
17194517	1652	1663	convulsions	Disease	MESH:D012640
17194517	1682	1686	BChE	Gene	12038
17194517	1726	1730	AChE	Gene	11423
17194517	1734	1738	mice	Species	10090
17194517	1796	1800	BChE	Gene	12038
17194517	1838	1851	acetylcholine	Chemical	MESH:D000109
17194517	1940	1944	BChE	Gene	12038
17194517	1994	2009	BChE deficiency	Disease	MESH:D007153
17194517	2070	2087	Alzheimer's drugs	Disease	MESH:D000544
17194517	2094	2105	huperzine A	Chemical	MESH:C050426
17194517	2110	2119	donepezil	Chemical	MESH:D000077265
17194517	Positive_Correlation	MESH:C009618	MESH:C535672
17194517	Positive_Correlation	MESH:D000077265	MESH:D064420
17194517	Negative_Correlation	MESH:C050426	MESH:C537417
17194517	Association	MESH:D012640	11423
17194517	Negative_Correlation	MESH:D000077265	MESH:C537417
17194517	Association	MESH:C050426	12038
17194517	Positive_Correlation	MESH:C009618	MESH:D012640
17194517	Association	MESH:C535672	12038
17194517	Association	MESH:D007153	12038
17194517	Negative_Correlation	MESH:C050426	11423
17194517	Association	MESH:D012640	12038
17194517	Negative_Correlation	MESH:D000077265	11423
17194517	Association	MESH:D000077265	12038
17194517	Positive_Correlation	MESH:C050426	MESH:D064420
17194517	Association	MESH:D064420	12038
17194517	Association	MESH:C535672	11423

